Defined Diagnostics

Defined Diagnostics was a private molecular and point-of-care diagnostics company formerly known as Wellstat Diagnostics. Public bankruptcy and litigation records describe the business as developing, and intending to manufacture, sell, and distribute small point-of-care diagnostic systems capable of running a broad range of clinical diagnostic tests. The company appears to have operated in the in vitro diagnostics and diagnostic instrumentation segment rather than therapeutics. Available public evidence indicates the business filed for Chapter 11 bankruptcy in April 2016 and its cases were later closed, so it does not appear to be an active operating company today. Limited public information is available on specific marketed products, pipeline programs, or current commercial operations under the Defined Diagnostics name.